Researchers reveal how SMIP004 anticancer compound targets prostate cancer cells

[News]

One major hallmark of cancer cells is their ability to survive under stressful conditions. A new study spearheaded by researchers at Sanford-Burnham Medical Research Institute reveals how a promising anticancer compound called SMIP004 specifically kills prostate cancer cells by compromising their ability to withstand environmental stress.

More... (http://www.news-medical.net/news/20130731/Researchers-reveal-how-SMIP004-anticancer-compound-targets-prostate-cancer-cells.aspx)